Novartis (NYSE:NVS) said today that it is launching a research study to better understand the daily challenges facing people with multiple sclerosis. The study is designed to collect data from physical tasks and symptoms using participants’ smartphones.
The company said it hopes to find new potential ways to measure treatment effectiveness.
Get the full story at our sister site, Drug Delivery Business News.
